Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 15:169:156-158.
doi: 10.1016/j.amjcard.2022.01.012. Epub 2022 Feb 12.

Healthcare Expenditure Associated With Polypharmacy in Older Adults With Cardiovascular Diseases

Min Ji Kwak  1 , Mihyun Chang  2 , Simbo Chiadika  3 , David Aguilar  4 , Elenir Avritscher  5 , Ashish Deshmukh  6 , Parag Goyal  7 , Dae Hyun Kim  8 , Rajender Aparasu  9 , Holly M Holmes  3
Affiliations

Healthcare Expenditure Associated With Polypharmacy in Older Adults With Cardiovascular Diseases

Min Ji Kwak et al. Am J Cardiol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement

Dr. Min Ji Kwak is supported by National Institute on Aging (1R24AG064025), and receives personal consultation fee from Endocrine and Diabetes Plus Clinic of Houston. Dr. Parag Goyal is supported by American Heart Association grant 20CDA35310455, National Institute on Aging grant K76AG064428, and Loan Repayment Program award L30AG060521; Dr. Goyal receives personal fees for medicolegal consulting related to heart failure; and has received honoraria from Akcea inc and Bionest inc. Dr. Dae Hyun Kim receives personal fees from Alosa Health and research funding from the National Institute of Health for projects unrelated to the current work. Dr. Holly Holmes received research funding from Healthcare Services Corporation, which is a foundation of Blue Cross Blue Shield, for a study of deprescribing. The funding is unrelated to the manuscript under consideration. Dr. Rajender Aparasu receives research funding from Astellas Inc., Incyte Corp., Gilead, and Novartis Inc. for projects unrelated to the current work. Other authors do not report any conflict of interest.

References

    1. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions, BMC Geriatr 2017;17:230–017–0621–2. - PMC - PubMed
    1. The Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey Background,; 2020.
    1. Haider SI, Johnell K, Thorslund M, Fastbom J. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992 – 2002, Int J Clin Pharmacol Ther 2007;45:643–653. - PubMed

Publication types